Hi-Tech develops and makes generic, prescription and OTC pharmaceutical products. The company's focus is on liquid and semi-solid ophthalmic, otic and inhalation products. On September 7 Hi-Tech ...

Should Hi-Tech Pharmacal Co. (NASDAQ:HITK) investors track the following data? To the average investor, there are tons of gauges investors can use to monitor stocks. A duo of the best are hedge fund ...

During the inaugural address, Prof Pushpito Kuamr Ghosh motivated the students to keep their ambitions high and work hard Sandeep Kumar, on the other hand spoke about the new skills today's engineers ...

Akorn (AKRX) and Hi-Tech Pharmacal (HITK) announced that they have entered into a definitive agreement under which Akorn will acquire Hi-Tech for $640M in cash. Hi-Tech is a specialty pharmaceutical ...

The 2012 to 2013 flu season has reached what is officially at pandemic levels. The government report last week showed that more than 7% of the deaths in the prior week were tied to flu-related ...

Hi-Tech Pharmacal Co. ( HITK) has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because HITK is now in overbought territory with an RSI value ...

What: David Seltzer, Chief Executive Officer of Hi-Tech Pharmacal Co., Inc. (HITK) will preside over the opening bell. Where: NASDAQ MarketSite - 4 Times Square - 43rd and Broadway - Broadcast Studio ...

Hi-Tech Pharmacal Co. (NASDAQ:HITK) investors should be aware of a decrease in support from the world’s most elite money managers lately. In the 21st century investor’s toolkit, there are tons of ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. The 2012 to 2013 flu season has reached what is ...